Lauren Wolff, DPM
Foot & Ankle Surgery · Hyannis, MANPI 1881156727
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,189 of the $4,707 with a category attached, or 67.8%. It is spread thinly across 15 manufacturers, the largest accounting for just 22.3%. Reporting peaked in 2022 at $1,345 and has fallen 90.1% since, to $133 in 2025.
Across 79 payments — averaging $59.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- Stryker$937
- Zimmer Biomet$897
- Kairos Surgical Inc$840
- Integra Lifesciences Corporation$199
- DJO, LLC$172
- plus $611 from 9 others
What the payments were for
- Travel & lodging$52911%
- Food & beverage$3,18968%
- Education$98921%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 22 | $1,051 |
| Stryker | 18 | $937 |
| Zimmer Biomet | 16 | $897 |
| Kairos Surgical Inc | 2 | $840 |
| Integra Lifesciences Corporation | 2 | $199 |
| DJO, LLC | 2 | $172 |
| Paratek Pharmaceuticals, Inc. | 5 | $133 |
| Treace Medical Concepts, Inc. | 3 | $114 |
| Bioventus LLC | 2 | $103 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $100 |
| Orthofix Medical, Inc. | 2 | $77 |
| Trilliant Surgical LLC. | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InCore Lapidus$445
- Stravix$221
- BILAYER WOUND MATRIX (BWM)$125
- INTEGRA WOUND MATRIX (IWM)$125
- PRIMATRIX$125
- IDRT$125
- FLOWABLE$125
- EVOS MINI$121
- EVOS$121
- ILIZAROV$121
- Panta 2$121
- ORTHOLOC 3DI$118
- Grafix PRIME$116
- Grafix CORE$116
- Grafix XC$116
- Grafix PL PRIME$116
- SALVATION$112
- ORTHOLOC 2 LAPIFUSE$106
- GRAFIX PL$105
How this compares
$4,707 in reported general payments places this provider in the 75th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 12 | $93 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Hyannis
- Richard BakerHyannis$16K
- Alfred PhillipsHyannis$9K
- Harry SchneiderCambridge$174K
- Craig LareauSpringfield$115K
- David SipalaBrighton$94K
- Philip BasileCambridge$90K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
- Mark SlovenkaiWaltham$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.